Drug Search Results
Using advanced filters...
Advanced Search [+]

Letrazuril

Alternative Names: letrazuril
Latest Update: 2005-06-24
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Institute of Allergy and Infectious Diseases (NIAID)
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: HIV Infections|Cryptosporidiosis|Diarrhea

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTG 198

P1

Completed

HIV Infections|Cryptosporidiosis|Diarrhea

None

Recent News Events

Date

Type

Title